Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Labcorp Declares Quarterly Dividend By: Labcorp via Business Wire October 12, 2022 at 16:45 PM EDT Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20221012006063/en/Contacts Labcorp Contacts: Investors: Chas Cook - 336-436-5076 Investor@Labcorp.com Media: Rachael Valdez - 336-436-8263 Media@Labcorp.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Labcorp Declares Quarterly Dividend By: Labcorp via Business Wire October 12, 2022 at 16:45 PM EDT Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20221012006063/en/Contacts Labcorp Contacts: Investors: Chas Cook - 336-436-5076 Investor@Labcorp.com Media: Rachael Valdez - 336-436-8263 Media@Labcorp.com
Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20221012006063/en/
Labcorp Contacts: Investors: Chas Cook - 336-436-5076 Investor@Labcorp.com Media: Rachael Valdez - 336-436-8263 Media@Labcorp.com